CME

00:16:00

Ready, Set, Act! Opportunities to Address Persistent...

CME ·

2026/08/24

Faculty: Carolyn Lam, MD, PhD Faculty: Stephen J. Greene, MD Using a real-world patient case, Dr. Stephen Greene and Dr. Carolyn Lam explore strategies to optimize care for patients with heart failure with reduced ejection fraction (HFrEF) who remain at elevated risk despite guideline-directed medical therapy (GDMT). The discussion examines the importance of avoiding clinical inertia, addressing persistent residual risk, and using biomarkers such as NT-proBNP to guide treatment

en

00:07:30

Building the Team: Integrating Immunotherapy Into...

CME ·

2026/07/23

Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for integrating immune checkpoint inhibitors before and after surgery and discuss emerging evidence from key clinical trials, including KEYNOTE-689 and NIVOPOSTOP. The discussions highlight

en

00:05:00

The Evidence Base: Key Trials and Emerging Data

CME ·

2026/07/23

Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for integrating immune checkpoint inhibitors before and after surgery and discuss emerging evidence from key clinical trials, including KEYNOTE-689 and NIVOPOSTOP. The discussions highlight

en

00:04:15

The Case for Change: Why Perioperative Immunotherapy...

CME ·

2026/07/23

Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for integrating immune checkpoint inhibitors before and after surgery and discuss emerging evidence from key clinical trials, including KEYNOTE-689 and NIVOPOSTOP. The discussions highlight

en

00:05:15

From Data to Decision: Patient Selection and...

CME ·

2026/07/23

Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for integrating immune checkpoint inhibitors before and after surgery and discuss emerging evidence from key clinical trials, including KEYNOTE-689 and NIVOPOSTOP. The discussions highlight

en

00:05:30

Precision in Practice—Bringing Targeted Therapy to mHSPC

CME ·

2026/07/20

Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy, and emerging targeted therapies. Drs. Scott Tagawa and Mary-Ellen Taplin discuss how disease volume, metastatic distribution, comorbidities, and patient goals inform individualized

en

00:07:00

The Power of Timing: Therapies That Change Outcomes

CME ·

2026/07/20

Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy, and emerging targeted therapies. Drs. Scott Tagawa and Mary-Ellen Taplin discuss how disease volume, metastatic distribution, comorbidities, and patient goals inform individualized

en

00:07:00

ADT Intensification in Biochemically Recurrent...

CME ·

2026/07/20

Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy, and emerging targeted therapies. Drs. Scott Tagawa and Mary-Ellen Taplin discuss how disease volume, metastatic distribution, comorbidities, and patient goals inform individualized

en

00:05:00

Cracking the Code: Risk Stratification Guidelines to...

CME ·

2026/07/20

Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy, and emerging targeted therapies. Drs. Scott Tagawa and Mary-Ellen Taplin discuss how disease volume, metastatic distribution, comorbidities, and patient goals inform individualized

en

00:07:15

Transitioning to Adult Care in Rett Syndrome:...

CME ·

2026/07/17

Faculty: Jennifer Martelle Tu, MD, PhD Faculty: Payal Kenia Gu, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure

en

00:06:00

Clinical Pearls in Adult Rett Syndrome Care:...

CME ·

2026/07/17

Faculty: Payal Kenia Gu, MD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure control,

en

00:06:30

Managing Rett Syndrome: Building a Multidisciplinary...

CME ·

2026/07/17

Faculty: Payal Kenia Gu, MD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure control,

en

00:05:00

Clinical Pearls in Rett Syndrome Management:...

CME ·

2026/07/17

Faculty: Jennifer Martelle Tu, MD, PhD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure

en

00:06:45

Clinical Pearls in Transition: Supporting Patients...

CME ·

2026/07/17

Faculty: Jennifer Martelle Tu, MD, PhD Faculty: Payal Kenia Gu, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure

en

00:07:15

Diagnosing Rett Syndrome: A Lifespan Approach to...

CME ·

2026/07/17

Faculty: Payal Kenia Gu, MD Faculty: Edward Dabrowski, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure control,

en

00:07:15

Managing Rett Syndrome: Building a Multidisciplinary...

CME ·

2026/07/17

Faculty: Jennifer Martelle Tu, MD, PhD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure

en

00:05:00

Clinical Pearls in Recognizing Rett Syndrome: Early...

CME ·

2026/07/17

Faculty: Payal Kenia Gu, MD Faculty: Edward Dabrowski, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure control,

en

00:04:30

What’s Next for TROP2-Directed ADCs in TNBC?

CME ·

2026/07/16

Faculty: Tiffany Traina, MD, FASCO This online educational activity examines the evolving role of TROP2-directed antibody-drug conjugates (ADCs) in the frontline management of metastatic triple-negative breast cancer (TNBC). Through expert-led reviews and case-based discussions, the activity compares pivotal clinical trial data for emerging ADCs, with a focus on patients who are not candidates for immunotherapy. Faculty discuss how efficacy, safety profiles, dosing considerations, and

en

00:10:00

Case Consult: First-Line Treatment in Metastatic TNBC...

CME ·

2026/07/16

Faculty: Tiffany Traina, MD, FASCO Faculty: Javier Cortes, MD, PhD This online educational activity examines the evolving role of TROP2-directed antibody-drug conjugates (ADCs) in the frontline management of metastatic triple-negative breast cancer (TNBC). Through expert-led reviews and case-based discussions, the activity compares pivotal clinical trial data for emerging ADCs, with a focus on patients who are not candidates for immunotherapy. Faculty discuss how efficacy, safety

en

00:04:45

Comparing First-Line TROP2-Directed ADCs in...

CME ·

2026/07/16

Faculty: Javier Cortes, MD, PhD This online educational activity examines the evolving role of TROP2-directed antibody-drug conjugates (ADCs) in the frontline management of metastatic triple-negative breast cancer (TNBC). Through expert-led reviews and case-based discussions, the activity compares pivotal clinical trial data for emerging ADCs, with a focus on patients who are not candidates for immunotherapy. Faculty discuss how efficacy, safety profiles, dosing considerations, and

en

All Episodes

Similar Podcasts

Ciência

RFI Português

天方烨谈

基因频道

Quilo de Ciencia - Cienciaes.com

Jorge Laborda

The Field Guides

The Field Guides

Down to Earth

FRANCE 24 English